Boothwyn Pharmacy recalled 648 vials of Semaglutide injection on July 9, 2025. The product is subpotent and poses a high hazard risk. Consumers should stop using the product immediately and contact their healthcare provider.
Subpotent Drug
Consumers and healthcare providers should stop using this product immediately. Contact Boothwyn Pharmacy LLC or your healthcare provider for guidance. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The recall pertains to Semaglutide, 2.5 mg/mL injection, packaged in 4 mL vials. Models include 03202025@2, 03202025@3, and 03202025@4 with a use-by date of July 18, 2025. The product was distributed nationwide in the U.S.
The recalled Semaglutide injection is classified as subpotent. This could lead to inadequate treatment for conditions it is prescribed for, potentially resulting in serious health risks.
No injuries or incidents have been reported at this time. The potential for health complications remains a concern due to the drug's subpotency.
Stop using the recalled Semaglutide injection immediately. Contact Boothwyn Pharmacy LLC or your healthcare provider for guidance on alternative treatments.
For more information, contact Boothwyn Pharmacy at their official channels or visit their FDA recall page.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.